维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="DAL NEGRO R"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Inhaled fluticasone propionate and salmeterol in adults asthma: Lung function and symptom显示文摘	Dal Negro R Colman NC	1998	Am J Respir Crit Care Med1998，157，：	1
2	Tobramycin Nebu- lizer Solution in severe COPD patients colonized with Pseudo- monas aeruginosa: effects on bronchial inflammation 显示文摘	Dal Negro R Micheletto C Tognella S	2008	Adv T- her2008，25，10：	1
3	Tobramycin Nebu- lizer Solution in severe COPD patients colonized with Pseudo- monas aeruginosa: effects on bronchial inflammation 显示文摘	Dal Negro R Micheletto C Toqnella S	2008	Adv T- her2008，25，10：	1
4	Essential amino acid supplementation in patients with severe COPD:a step towards home rehabilitation显示文摘	Dal Negro RW Testa A Aquilani R	2012	Monaldi Arch Chest Dis2012，77，2：	1
5	Importance of inhaler devices in the management of airway disease显示文摘	Virchow JC Crompoton GK Dal Negro R	2008	Respiratory Medicine2008，102，1：	1
6	Addition of salmeter- roI to fluticasone prop显示文摘	Ind PW Dal Negro R Colman NC	2003	Respir Med2003，97，5：	1
7	Importance of inhaler devices in the management of airway disease显示文摘	Virchow JC Crompton GK Dal Negro R	2008	Respiratory Medi-eine2008，102，1：	1
8	Inhaled fluticasone profionate and salmeterol in adults asthma: Lung function and symptom显示文摘	Ind PW Dal Negro R Colman NC	1998	Am J Respir Crit Med1998，157，：	1
9	Inhaled fluticasone profionate and salmeterol in adults asthma:lung function and symptom显示文摘	Ind PW Dal Negro R Colman NC	1998	Am J Respir Crit Med1998，157，：	1
10	Changes of clinical outcomes and health care resources in moderate and in severe COPD treated uniquely with tiotropium 18 mcg od for twenty-four months 显示文摘	DAL NEGRO R W BONADIMAN LBONADIMAN L MICHELETYO C	2011	Pulm Pharmacol Ther2011，24，4：	1
11	Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma显示文摘	Dal Negro R Col man NC	2003	Respir Med2003，97，5：	1
12	Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma显示文摘	Ind PW Dal Negro R Colman NC	2003	Respir Med2003，97，5：	1
13	(2007) Changes in blood ROS, e-NO, and some proinflammatory mediators in bronchial secretions following Erdosteine or placebo:a controlled study in current smokers with mild COPD 显示文摘	Dal Negro R W Visconti M Mieheletto C	2008	Pulm Pharmacol Ther2008，21，2：	1
14	Addition of salmeterol to fluticasone proprionate treatment in moderate to severe asthma显示文摘	Ind PW Dal Negro R Colman NC	2003	Respir Med2003，97，5：	1
15	Addition of salmeterrol to fluticasone propionate treatment in moderate-to-severe asthma显示文摘	Ind PW Dal Negro R Colman NC	2003	Respir Med2003，97，5：	1
16	Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients显示文摘	Riccio A M Dal Negro R W Micheletto C	2012	Int J Immunopathol Pharmacol2012，25，2：	1
17	Inhaled fluticasonepropionate and salmeterol in adults asthma: lung function and symptom显示文摘	IND P W DAL NEGRO R COLMAN N C	1998	Am J Respir Crit Care Med1998，157，：	1
18	Essential amino acid supplementation in patients with severe COPD: a step towardshome rehabilitation 显示文摘	Dal Negro RW Testa A Aquilani R	2012	Monaldi Arch Chest Dis2012，77，2：	1
19	Inhaled fluticasone Propionate and salmeterol in adults asthma: lung function and symptom显示文摘	Ind PW Dal Negro R	1998	Am J Respir Crit care Med1998，157，：	1
20	Importance of inhaler devices in the management of airway disease显示文摘	Virchow JC Crompton GK Dal Negro R		0，，24：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示